Stomach Neoplasms: all 2,914 studies
Page 6 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasRecruitingNCT06346197Phase 3
- Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric CancerRecruitingNCT06346093Not applicable
- Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice ExperimentRecruitingNCT06346080Not applicable
- Molecular Assessment for Gastro-Esophageal CancerRecruitingNCT06346054Not applicable
- Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALMRecruitingNCT06341595Phase 2
- BCAA in Patients Undergoing Gastric Cancer SurgeryNot yet recruitingNCT06340399Not applicable
- A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.Not yet recruitingNCT06339216Phase 2
- Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical ApplicationNot yet recruitingNCT06335576
- The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric CancerRecruitingNCT06327386
- Microbiota in Gastric Cancer by Gastric Mucosal BrushingRecruitingNCT06325891
- Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC SessionsRecruitingNCT06313801Phase 2
- Metronomic Capecitabine in Stage III Gastric CancerRecruitingNCT06313567Phase 3
- Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer TrialNot yet recruitingNCT06310473Phase 2
- Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric CancerRecruitingNCT06308510
- Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric CancerRecruitingNCT06306755Not applicable
- Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric CancerNot yet recruitingNCT06305169
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerRecruitingNCT06298916Phase 1/2
- A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerRecruitingNCT06296706Phase 3
- The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.Not yet recruitingNCT06295094Phase 2
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric CancerRecruitingNCT06284746Phase 2
- A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric CancerNot yet recruitingNCT06283121Phase 2
- Postoperative Morbidity and Mortality After Gastric Cancer SurgeryNot yet recruitingNCT06277908
- GAIN Project: Gastric Cancer and Artificial IntelligenceNot yet recruitingNCT06275997Not applicable
- H. Pylori Screen-and-treat Study in a Population of Young AdultsRecruitingNCT06275204
- SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric CancerNot yet recruitingNCT06266871Phase 1/2
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.RecruitingNCT06263088Not applicable
- Online Exercise Program During Perioperative Treatment in Adults With Gastric CancerRecruitingNCT06254300Not applicable
- A Phase 1/1b Study of IAM1363 in HER2 CancersRecruitingNCT06253871Phase 1
- Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual DiseaseRecruitingNCT06253650Phase 2
- First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric CancerRecruitingNCT06253611Phase 2
- National Multicenter Cohort Study of Robot-Assisted Gastrectomy Versus Laparoscopy in Gastric CancerEnrolling by invitationNCT06242613
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJCNot yet recruitingNCT06238167Phase 2
- An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-IIRecruitingNCT06232434Phase 2/3
- Early Detection and Post-operative Monitoring of Gastric CancerRecruitingNCT06232395
- Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric CancerNot yet recruitingNCT06229197Not applicable
- Orelabrutinib in the Treatment of HP-positive Gastric MALT LymphomaRecruitingNCT06228963Phase 2
- Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.RecruitingNCT06227728
- Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 OverexpressionNot yet recruitingNCT06227325Phase 2
- Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal MetastasesNot yet recruitingNCT06224738Early Phase 1
- Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJANot yet recruitingNCT06222944Phase 2
- PPG vs. ICG in Gastrointestinal ResectionsRecruitingNCT06222645Not applicable
- DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line TherapyRecruitingNCT06221748Phase 2/3
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RecruitingNCT06219941Phase 2
- HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT06213519Phase 2
- Atrophic Gastritis Predicts the Risk of Gastric CancerRecruitingNCT06203327
- Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscoreNot yet recruitingNCT06202716Phase 2
- Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric CancerRecruitingNCT06202105Not applicable
- Exploratory Study of Single-port Robot-assisted GastrectomyNot yet recruitingNCT06201585Not applicable
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerRecruitingNCT06199895Phase 2
- Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric CancerNot yet recruitingNCT06197438Phase 2
- Gastric Cancer Organoids in the Screening of Neoadjuvant DrugsRecruitingNCT06196554
- Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 StageRecruitingNCT06194981
- Effect of Gastrectomy on Gut Microbiome and Cognitive FunctionRecruitingNCT06186089
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric CancerRecruitingNCT06169410Phase 4
- 3D-4K-ICG Laparoscopic Gastrectomy for Gastric CancerRecruitingNCT06161207Phase 3
- Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscoreRecruitingNCT06157996Phase 2
- Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT06155383Phase 2
- 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine TumoursRecruitingNCT06155318
- LCI in Chronic Atrophic Gastritis and Early Gastric CancerRecruitingNCT06152263
- NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorRecruitingNCT06134960Phase 1
- A Study of SGN-CEACAM5C in Adults With Advanced Solid TumorsRecruitingNCT06131840Phase 1
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric CancerRecruitingNCT06128252Not applicable
- Analgesia Nociception Index-guided Anesthesia and Standard AnesthesiaNot yet recruitingNCT06123637Not applicable
- SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing RegimenRecruitingNCT06123494Phase 3
- Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric CancerRecruitingNCT06123455Phase 2
- Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ CancerRecruitingNCT06121700Phase 2
- Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) TrialNot yet recruitingNCT06115629Phase 3
- Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric CancerRecruitingNCT06105515Not applicable
- Fruquintinib Combined With TAS102 for Advanced Gastric CancerRecruitingNCT06102785
- Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric CancerRecruitingNCT06102772
- Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody FailedRecruitingNCT06102759
- A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing MethodRecruitingNCT06100003
- Safety and Efficacy of NK510 to Treat Gastric CancerEnrolling by invitationNCT06098898Early Phase 1
- Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced CancerNot yet recruitingNCT06094868Phase 2
- Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ AdenocarcinomaNot yet recruitingNCT06093425Phase 3
- XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter StudyRecruitingNCT06091423Phase 2
- Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric CancerRecruitingNCT06085755Phase 1/2
- The Gastric HormonE BioMarkers of Preneoplastic Lesions StudyNot yet recruitingNCT06085677
- Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric CancerRecruitingNCT06078982Phase 1
- Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes MechanismsRecruitingNCT06078930
- Quantitative Detection of CEA mRNA in the Smog and Tissue Exudate Whole Process Collected During Laparoscopic (Robotic) Radical Gastrectomy in Gastric Cancer PatientsRecruitingNCT06076265
- Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyRecruitingNCT06065371Phase 1
- RCT of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Ocular Adnexal MALT LymphomaNot yet recruitingNCT06064344Not applicable
- Frailty Assessment and Intervention in Elderly Patients with Gastric Cancer Receiving Gastrectomy and Adjuvant ChemotherapyRecruitingNCT06055387Not applicable
- Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric CancerRecruitingNCT06054906Phase 2
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric CancerRecruitingNCT06047158
- Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT06046963Phase 2
- Prehabilitation Via a Mobile Application in Oesophago-gastric CancerNot yet recruitingNCT06046846Not applicable
- A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric CancerRecruitingNCT06042998Not applicable
- A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric CancerRecruitingNCT06038578Phase 2
- Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX RegimenRecruitingNCT06036745Phase 2
- AI Prediction of Gastric Cancer Response to Neoadjuvant ChemotherapyRecruitingNCT06035250
- Endoscopic Submucosal Dissection RegistryRecruitingNCT06033976
- The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric CancerRecruitingNCT06033482